Pharmafile Logo
Pharmafocus logo
Advanced Search

Connecting with patients

February 8, 2005
Medical Communications

In order for a clinical trial to be viable, it needs patients. Sounds obvious, but despite the fact that patients …

Feature

New depression treatment launched in the UK

February 3, 2005
Sales and Marketing

Lilly and Boehringer Ingelheim's depression treatment Cymbalta has been launched in the UK where it will do battle in the …

News

New ‘economic damage’ offence to beat animal activists

February 3, 2005
Sales and Marketing

The government has unveiled new laws to counteract the intimidation tactics used by activists to undermine animal research. Animal rights …

News

‘Smarter steroid’ Alvesco launched in the UK

February 3, 2005
Sales and Marketing

Alvesco, the first one puff, once-daily inhaled corticosteroid for asthma has been launched in the UK, its first European market.Manufacturers …

News

Aspirin plus PPI better than Plavix in patients with GI bleed

February 2, 2005
Sales and Marketing

A new study has concluded that aspirin plus a proton pump inhibitor (PPI) is more effective than Plavix (clopidogrel) in …

News

BMJ apologises for Prozac accusations

February 2, 2005
Sales and Marketing

The BMJ has retracted its allegations that Eli Lilly suppressed important safety information on its antidepressant drug Prozac during litigation …

News

AstraZeneca remains strong despite setbacks

February 1, 2005
Sales and Marketing

AstraZeneca has announced impressive full-year figures for 2004 despite its market value slumping by nearly a third in the past …

News

Merck hit by US patent blow

February 1, 2005
Sales and Marketing

Merck has lost 10 years of US patent protection for the best-selling formulation of its second-biggest selling drug, following a …

News

Overdose deaths lead to co-proxamol withdrawal

February 1, 2005
Sales and Marketing

Co-proxamol, a commonly prescribed painkiller, will be withdrawn from use in the UK because of continued deaths from overdose.The drug …

News

Changing the headlines

February 1, 2005
Medical Communications

'You kill people, don't you?' someone said to me when I mentioned my job was in pharma market research. Statements …

Feature

NHS Trust – can pharma win it?

February 1, 2005

Sometimes pharma companies could be forgiven for thinking they are in a catch-22 situation. On the one hand local NHS …

Feature

Open up to expert patients

January 28, 2005
Medical Communications

The pharma industry has a crucial role to play in the successful roll-out of the Expert Patients Programme (EPP) and …

Feature

Humira tipped for blockbuster status in 2005

January 25, 2005
Sales and Marketing

Abbott Laboratories has raised its sales expectations for rheumatoid arthritis treatment Humira and now expects the product's sales to reach …

News

Lipitor breaks $10 billion annual sales mark

January 21, 2005
Sales and Marketing

Pfizer's blockbuster statin Lipitor scaled new sales heights in 2004, becoming the first pharma product to make more than $10 …

News

MHRA admits to shortcomings

January 21, 2005
Sales and Marketing

The MHRA has admitted that it has "suffered from not being professional enough" as it endeavoured to restore its reputation …

News

UK industry seizes initiative to head off call for new laws

January 21, 2005

The UK pharmaceutical industry has put forward new proposals to reform itself and its relations with regulators and patients in …

News

Plavix leads the way in UK sales growth

January 20, 2005
Sales and Marketing

News

AstraZeneca looks to oncology pipeline after failure of Iressa

January 20, 2005
Sales and Marketing

AstraZeneca has withdrawn its marketing application for its lung cancer drug Iressa in the European Union following the release of …

News

FDA blocks self-diagnosis over-the-counter statin Mevacor

January 20, 2005
Medical Communications

Merck and Johnson & Johnson's application to sell the statin Mevacor (lovastatin) has failed to gain approval from an FDA …

News

Pfizer survey shows UK patients want greater information

January 20, 2005
Medical Communications

Nearly half of UK patients with long-term conditions don't think they have enough information about their disease and that this …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026